|
1
|
Krassas GE, Pontikides N, Tziomalos K, Tzotzas T, Zosin I, Vlad M, Luger A, Gessl A, Marculescu R, Toscano V, Morgante S, Papini E, Pirags V, Konrade I, Hybsier S, Hofmann PJ, Schomburg L, Köhrle J. Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries. Expert Rev Endocrinol Metab 2014; 9:685-692. [PMID: 30736204 DOI: 10.1586/17446651.2014.960845] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
CONTEXT Selenium supplementation has been suggested for Hashimoto thyroiditis and Graves' ophthalmopathy. Objective, Design: Our aim is to measure selenium status (p-Se, p-SePP), urine iodine (UI) levels and urine iodine/creatinine ratio (UI/C) in different thyroid diseases (n = 416) from four European countries and to compare the results between patients with and without thyroid autoimmunity. RESULTS p-Se and p-SePP showed positive correlation and did not correlate with UI/C. Also, these measurements were higher in patients from Italy in comparison with the other countries. Austria had the lowest UI/C ratios. Selenium deficiency exists in these four European countries. Selenium status was lower in patients with Hashimoto thyroiditis and Graves' disease in comparison with non-autoimmune thyroid disease patients and did not differ between autoimmune patients with or without thyroid peroxidase antibodies. The latter correlated positively with age. CONCLUSIONS Our findings suggest that Se supplementation might have a beneficial effect in autoimmune thyroid patients.
Collapse
Affiliation(s)
- Gerasimos E Krassas
- a Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Tsimiski 92, 54622 Thessaloniki, Greece
| | - Nikolaos Pontikides
- a Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Tsimiski 92, 54622 Thessaloniki, Greece
| | - Kostas Tziomalos
- a Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Tsimiski 92, 54622 Thessaloniki, Greece
| | - Themistoklis Tzotzas
- a Department of Endocrinology, Diabetes and Metabolism, Panagia General Hospital, Tsimiski 92, 54622 Thessaloniki, Greece
| | - Ioana Zosin
- b Clinic of Endocrinology, University of Medicine and Pharmacy Timisoara, Timosoara, Romania
| | - Mihaela Vlad
- b Clinic of Endocrinology, University of Medicine and Pharmacy Timisoara, Timosoara, Romania
| | - Anton Luger
- c Department of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
| | - Alois Gessl
- c Department of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
| | - Rodrig Marculescu
- d Clinical Institute of Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
| | - Vincenzo Toscano
- e Department of Medicine, Clinical and Molecular Endocrinology, La Sapienza University of Rome, Rome, Italy
| | - Sara Morgante
- e Department of Medicine, Clinical and Molecular Endocrinology, La Sapienza University of Rome, Rome, Italy
| | - Enrico Papini
- f Department of Endocrinology and Metabolism, Hospital Regina Apostolorum - Albano Laziale, Rome, Italy
| | - Valdis Pirags
- g Department of Endocrinology, Pauls Stradins Clinical University Hospital, Riga, Latvia
| | - Ilze Konrade
- h Department of Endocrinology, Riga East Clinical University Hospital, Riga, Latvia
| | - Sandra Hybsier
- i Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Peter J Hofmann
- i Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Lutz Schomburg
- i Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Josef Köhrle
- i Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| |
Collapse
|